ID   HEPD_STRVR              Reviewed;         443 AA.
AC   Q5IW40; D9XF44; Q4JFE9;
DT   03-APR-2013, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 2.
DT   24-JUN-2015, entry version 51.
DE   RecName: Full=2-hydroxyethylphosphonate dioxygenase;
DE            EC=1.13.11.72;
DE   AltName: Full=Hydroxyethylphosphonate dioxygenase;
DE   AltName: Full=Phosphinothricin tripeptide biosynthesis protein D;
GN   Name=hepD; Synonyms=phpD; ORFNames=SSQG_01041;
OS   Streptomyces viridochromogenes.
OC   Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC   Streptomyces.
OX   NCBI_TaxID=1938;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Tu494;
RX   PubMed=8593056;
RA   Schwartz D., Alijah R., Nussbaumer B., Pelzer S., Wohlleben W.;
RT   "The peptide synthetase gene phsA from Streptomyces viridochromogenes
RT   is not juxtaposed with other genes involved in nonribosomal
RT   biosynthesis of peptides.";
RL   Appl. Environ. Microbiol. 62:570-577(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=DSM 40736;
RX   PubMed=15616300; DOI=10.1128/AAC.49.1.230-240.2005;
RA   Blodgett J.A., Zhang J.K., Metcalf W.W.;
RT   "Molecular cloning, sequence analysis, and heterologous expression of
RT   the phosphinothricin tripeptide biosynthetic gene cluster from
RT   Streptomyces viridochromogenes DSM 40736.";
RL   Antimicrob. Agents Chemother. 49:230-240(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=DSM 40736;
RG   The Broad Institute Genome Sequencing Platform, Broad Institute Microbial Sequencing Center;
RA   Fischbach M., Godfrey P., Ward D., Young S., Zeng Q., Koehrsen M.,
RA   Alvarado L., Berlin A.M., Bochicchio J., Borenstein D., Chapman S.B.,
RA   Chen Z., Engels R., Freedman E., Gellesch M., Goldberg J., Griggs A.,
RA   Gujja S., Heilman E.R., Heiman D.I., Hepburn T.A., Howarth C., Jen D.,
RA   Larson L., Lewis B., Mehta T., Park D., Pearson M., Richards J.,
RA   Roberts A., Saif S., Shea T.D., Shenoy N., Sisk P., Stolte C.,
RA   Sykes S.N., Thomson T., Walk T., White J., Yandava C., Straight P.,
RA   Clardy J., Hung D., Kolter R., Mekalanos J., Walker S., Walsh C.T.,
RA   Wieland-Brown L.C., Haas B., Nusbaum C., Birren B.;
RT   "Annotation of Streptomyces viridochromogenes strain DSM 40736.";
RL   Submitted (FEB-2009) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION.
RC   STRAIN=DSM 40736;
RX   PubMed=17632514; DOI=10.1038/nchembio.2007.9;
RA   Blodgett J.A., Thomas P.M., Li G., Velasquez J.E., van der Donk W.A.,
RA   Kelleher N.L., Metcalf W.W.;
RT   "Unusual transformations in the biosynthesis of the antibiotic
RT   phosphinothricin tripeptide.";
RL   Nat. Chem. Biol. 3:480-485(2007).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND REACTION MECHANISM.
RX   PubMed=19839620; DOI=10.1021/ja906238r;
RA   Whitteck J.T., Cicchillo R.M., van der Donk W.A.;
RT   "Hydroperoxylation by hydroxyethylphosphonate dioxygenase.";
RL   J. Am. Chem. Soc. 131:16225-16232(2009).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND REACTION MECHANISM.
RX   PubMed=21381767; DOI=10.1021/ja1113326;
RA   Whitteck J.T., Malova P., Peck S.C., Cicchillo R.M., Hammerschmidt F.,
RA   van der Donk W.A.;
RT   "On the stereochemistry of 2-hydroxyethylphosphonate dioxygenase.";
RL   J. Am. Chem. Soc. 133:4236-4239(2011).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH COBALT,
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND PATHWAY.
RX   PubMed=19516340; DOI=10.1038/nature07972;
RA   Cicchillo R.M., Zhang H., Blodgett J.A., Whitteck J.T., Li G.,
RA   Nair S.K., van der Donk W.A., Metcalf W.W.;
RT   "An unusual carbon-carbon bond cleavage reaction during
RT   phosphinothricin biosynthesis.";
RL   Nature 459:871-874(2009).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) IN COMPLEX WITH COBALT AND
RP   2-HYDROXYETHYLPHOSPHONATE, SUBUNIT, FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF LYS-16; ARG-90 AND
RP   TYR-98.
RX   PubMed=21711001; DOI=10.1021/bi200804r;
RA   Peck S.C., Cooke H.A., Cicchillo R.M., Malova P., Hammerschmidt F.,
RA   Nair S.K., van der Donk W.A.;
RT   "Mechanism and substrate recognition of 2-hydroxyethylphosphonate
RT   dioxygenase.";
RL   Biochemistry 50:6598-6605(2011).
CC   -!- FUNCTION: Non-heme-dependent dioxygenase that catalyzes the
CC       conversion of 2-hydroxyethylphosphonate (HEP) to
CC       hydroxymethylphosphonate (HMP) in the biosynthesis of
CC       phosphinothricin tripeptide (PTT). PTT contains the unusual amino
CC       acid phosphinothricin attached to 2 alanine residues. Synthetic
CC       phosphinothricin (glufosinate) is a key component of commercial
CC       herbicides. {ECO:0000269|PubMed:17632514,
CC       ECO:0000269|PubMed:19516340, ECO:0000269|PubMed:19839620,
CC       ECO:0000269|PubMed:21381767, ECO:0000269|PubMed:21711001}.
CC   -!- CATALYTIC ACTIVITY: 2-hydroxyethylphosphonate + O(2) =
CC       hydroxymethylphosphonate + formate. {ECO:0000269|PubMed:19516340,
CC       ECO:0000269|PubMed:19839620, ECO:0000269|PubMed:21381767,
CC       ECO:0000269|PubMed:21711001}.
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000269|PubMed:19516340};
CC       Note=Binds 1 Fe(2+) ion per subunit.
CC       {ECO:0000269|PubMed:19516340};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=9.8 uM for 2-hydroxyethylphosphonate
CC         {ECO:0000269|PubMed:21711001};
CC         KM=33 uM for O(2) {ECO:0000269|PubMed:21711001};
CC         Note=kcat is 0.35 sec(-1).;
CC   -!- PATHWAY: Phosphorus metabolism; phosphonate biosynthesis.
CC       {ECO:0000269|PubMed:19516340}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:19516340,
CC       ECO:0000269|PubMed:21711001}.
CC   -!- MISCELLANEOUS: Mediates the cleavage of the carbon-carbon bond of
CC       2-hydroxyethylphosphonate (HEP) to produce
CC       hydroxymethylphosphonate (HMP) and formate without input of
CC       electrons or use of any organic cofactors. Reaction was initially
CC       supposed to follow a Criegee rearrangement with a phosphorus-based
CC       migrating group (PubMed:19839620). However, it was laster shown
CC       that it is not the case (PubMed:21381767).
CC       {ECO:0000305|PubMed:19839620, ECO:0000305|PubMed:21381767}.
CC   -!- MISCELLANEOUS: Phosphinothricin tripeptide (PTT) herbicide and
CC       fosfomycin antibiotic biosynthesiz pathways share early steps
CC       starting with phosphoenolpyruvate before the pathways diverge
CC       after formation of 2-hydroxyethylphosphonate (HEP)
CC       (PubMed:17632514). HepD is involved in phosphinothricin tripeptide
CC       (PTT) herbicide biosynthesis after divergence of the 2 pathways
CC       (PubMed:19516340). {ECO:0000305|PubMed:17632514,
CC       ECO:0000305|PubMed:19516340}.
CC   -!- SIMILARITY: Belongs to the non-heme iron-dependent dioxygenase
CC       family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 HTH cro/C1-type DNA-binding domains.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAJ14042.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X65195; CAJ14042.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY632421; AAU00079.2; -; Genomic_DNA.
DR   EMBL; GG657757; EFL30523.1; -; Genomic_DNA.
DR   PDB; 3G7D; X-ray; 1.80 A; A=1-443.
DR   PDB; 3GBF; X-ray; 1.92 A; A=1-443.
DR   PDB; 3RZZ; X-ray; 2.20 A; A=1-443.
DR   PDB; 4YAR; X-ray; 1.75 A; A=1-443.
DR   PDBsum; 3G7D; -.
DR   PDBsum; 3GBF; -.
DR   PDBsum; 3RZZ; -.
DR   PDBsum; 4YAR; -.
DR   ProteinModelPortal; Q5IW40; -.
DR   DIP; DIP-59765N; -.
DR   STRING; 591159.SSQG_01041; -.
DR   EnsemblBacteria; EFL30523; EFL30523; SSQG_01041.
DR   BioCyc; MetaCyc:MONOMER-15041; -.
DR   BRENDA; 1.13.11.72; 6116.
DR   UniPathway; UPA00960; -.
DR   EvolutionaryTrace; Q5IW40; -.
DR   GO; GO:0008198; F:ferrous iron binding; IDA:UniProtKB.
DR   GO; GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0032923; P:organic phosphonate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:1901766; P:phosphinothricin biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 1.10.260.40; -; 1.
DR   InterPro; IPR001387; Cro/C1-type_HTH.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR011051; RmlC_Cupin.
DR   SMART; SM00530; HTH_XRE; 2.
DR   SUPFAM; SSF51182; SSF51182; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Dioxygenase; DNA-binding; Iron; Metal-binding;
KW   Oxidoreductase; Repeat.
FT   CHAIN         1    443       2-hydroxyethylphosphonate dioxygenase.
FT                                /FTId=PRO_0000422032.
FT   DOMAIN        8     63       HTH cro/C1-type 1.
FT   DOMAIN      234    290       HTH cro/C1-type 2.
FT   DNA_BIND     19     38       H-T-H motif. {ECO:0000250}.
FT   DNA_BIND    245    265       H-T-H motif. {ECO:0000250}.
FT   METAL       129    129       Iron; via tele nitrogen.
FT   METAL       182    182       Iron; via tele nitrogen.
FT   BINDING      16     16       Substrate; shared with dimeric partner.
FT   BINDING      98     98       Substrate.
FT   BINDING     126    126       Substrate.
FT   BINDING     176    176       Substrate.
FT   MUTAGEN      16     16       K->A: Abolishes 2-hydroxyethylphosphonate
FT                                dioxygenase activity.
FT                                {ECO:0000269|PubMed:21711001}.
FT   MUTAGEN      90     90       R->A: Results in a much higher apparent
FT                                KM for 2-hydroxyethylphosphonate. Caanot
FT                                be saturated in (O2).
FT                                {ECO:0000269|PubMed:21711001}.
FT   MUTAGEN      98     98       Y->F: Still able to convert 2-
FT                                hydroxyethylphosphonate to
FT                                hydroxymethylphosphonate and formate;
FT                                however, in contrast to wild-type enzyme
FT                                which consumes O(2) without a loss of
FT                                catalytic activity, the rate of
FT                                consumption of O(2) gradually decreases
FT                                until the enzyme has lost all activity
FT                                well before substrate has been consumed.
FT                                {ECO:0000269|PubMed:21711001}.
FT   HELIX         5     15       {ECO:0000244|PDB:4YAR}.
FT   HELIX        19     26       {ECO:0000244|PDB:4YAR}.
FT   HELIX        30     36       {ECO:0000244|PDB:4YAR}.
FT   STRAND       37     39       {ECO:0000244|PDB:4YAR}.
FT   TURN         43     46       {ECO:0000244|PDB:4YAR}.
FT   HELIX        49     55       {ECO:0000244|PDB:4YAR}.
FT   HELIX        60     62       {ECO:0000244|PDB:4YAR}.
FT   STRAND       73     76       {ECO:0000244|PDB:4YAR}.
FT   HELIX        78     82       {ECO:0000244|PDB:4YAR}.
FT   STRAND       86     90       {ECO:0000244|PDB:4YAR}.
FT   STRAND       93    100       {ECO:0000244|PDB:4YAR}.
FT   STRAND      111    115       {ECO:0000244|PDB:4YAR}.
FT   STRAND      133    141       {ECO:0000244|PDB:4YAR}.
FT   STRAND      143    146       {ECO:0000244|PDB:4YAR}.
FT   STRAND      148    150       {ECO:0000244|PDB:4YAR}.
FT   TURN        153    155       {ECO:0000244|PDB:4YAR}.
FT   STRAND      156    159       {ECO:0000244|PDB:4YAR}.
FT   STRAND      173    176       {ECO:0000244|PDB:4YAR}.
FT   STRAND      183    190       {ECO:0000244|PDB:4YAR}.
FT   STRAND      192    198       {ECO:0000244|PDB:4YAR}.
FT   HELIX       204    210       {ECO:0000244|PDB:4YAR}.
FT   HELIX       215    224       {ECO:0000244|PDB:4YAR}.
FT   HELIX       231    241       {ECO:0000244|PDB:4YAR}.
FT   HELIX       246    253       {ECO:0000244|PDB:4YAR}.
FT   HELIX       257    265       {ECO:0000244|PDB:4YAR}.
FT   HELIX       270    283       {ECO:0000244|PDB:4YAR}.
FT   HELIX       287    290       {ECO:0000244|PDB:4YAR}.
FT   STRAND      298    300       {ECO:0000244|PDB:3RZZ}.
FT   TURN        301    303       {ECO:0000244|PDB:4YAR}.
FT   HELIX       307    312       {ECO:0000244|PDB:4YAR}.
FT   STRAND      315    317       {ECO:0000244|PDB:4YAR}.
FT   STRAND      320    324       {ECO:0000244|PDB:4YAR}.
FT   STRAND      335    345       {ECO:0000244|PDB:4YAR}.
FT   STRAND      353    363       {ECO:0000244|PDB:4YAR}.
FT   STRAND      365    371       {ECO:0000244|PDB:4YAR}.
FT   STRAND      374    380       {ECO:0000244|PDB:4YAR}.
FT   STRAND      385    388       {ECO:0000244|PDB:4YAR}.
FT   STRAND      394    407       {ECO:0000244|PDB:4YAR}.
FT   HELIX       413    420       {ECO:0000244|PDB:4YAR}.
FT   STRAND      422    424       {ECO:0000244|PDB:4YAR}.
FT   HELIX       425    430       {ECO:0000244|PDB:4YAR}.
SQ   SEQUENCE   443 AA;  48091 MW;  5ADBA86C73E65B48 CRC64;
     MRIDPFKLAH WMNARKYTAA QTADLAGLPL DDLRRLLGDE ANEPDPAAAT ALAEALSVEP
     SQLAADAHRN LTVVHKSAEE MHASRRPIQR DGIHFYNYYT LAAPEGRVAP VVLDILCPSD
     RLPALNNGHL EPAITVNLGP GDINGRWGEE ITPQTWRVLH ANHGGDRWIT GDSYVEPSYC
     PHSYSLAGDA PARIVSYTAQ SNISPLMTEA NNWSTGAFEE ALKALSGKVS AGSVLDLFLA
     RRAHTRTSAA EAAGVPPADL EAALRSPASE TGLTVLRTLG RALGFDYRVL LPADDQHDGV
     GKTWTTIEDS RRSRRTFGTY EAASMASAAH LPDLVGSFLR VDADGRGADL IDHAENHYVV
     TEGRLTLEWD GPDGPASVEL EPDGSAWTGP FVRHRWHGTG TVLKFGSGAH LGYQDWLELT
     NTFEPAATLR RGRRDLAGWG YDN
//
